Latest / The Pivot Podcast with Fexingo: How Businesses Change Direction and Survive Disruption / How Aetna Rebuilt Itself Around Preventive Care
Transcript
- Lucas: So this is episode one hundred fifty of the show, and I wanted to mark it with a pivot that's arguably the most consequential one we've covered: a one hundred seventy year old health insurance company deciding that its entire business model — getting paid to cover sickness — had to be rebuilt around keeping people well. Luna: You're talking about Aetna, right? The company that basically invented the modern health insurance policy in the eighteen fifties? Lucas: Exactly. Aetna started in eighteen fifty-three, and for most of its history, its job was simple: collect premiums, pay claims, and hope the math works out. The entire industry was built on that. But over the last decade, Aetna has been trying to flip the model on its head — to make money by keeping people healthy, not by processing their diseases. Luna: That sounds like a noble goal, but also a massive operational shift. How do you even start something like that? Lucas: You start with data. Aetna has one of the largest claims databases in the country — tens of millions of members, decades of medical history. And they began mining it not to price premiums more accurately, but to predict who was going to get sick and intervene before they did. They call it predictive health, and it's the core of their pivot. Luna: So give me a concrete example. What does that actually look like in practice? Lucas: Take type two diabetes. The average annual cost of managing a diabetic patient with complications can be north of twenty thousand dollars a year. But if you can identify someone who's pre-diabetic — their blood sugar is creeping up, their weight is trending, their prescriptions show early warning signs — and you get them into a lifestyle intervention program, you can cut that cost by more than half. Aetna's data showed them exactly who was at risk, years before a formal diagnosis. Luna: And that's not just good for the member, it's good for the bottom line. But insurance companies have always had a tricky relationship with prevention, right? I mean, if you spend money on keeping someone healthy, they might switch plans next year and you never see the payoff. Lucas: That's the classic problem, and it's why so many insurers pay lip service to wellness programs but never really commit. The savings from prevention often accrue over five, ten years, but the average member stays with an insurer for maybe three. So why spend the money? Aetna's answer was to change the contract itself. Luna: Change the contract? You mean not the insurance policy, but the business arrangement with employers? Lucas: Yes. Aetna started offering value-based contracts to employers, where they share some of the premium back if they hit certain health outcome targets. If they get a workforce's cholesterol down, or reduce hospital readmissions, they earn a bonus. That aligns the incentive: Aetna makes more money when their members are healthier, and the employer sees lower overall healthcare spend. It's a fundamental shift from fee for service to fee for health. Luna: That sounds promising, but I imagine the hardest part is actually changing the behavior of doctors and members, not just the actuarial tables. Lucas: Exactly right. And this is where the pivot gets really interesting. Aetna realized that their data wasn't just for predicting risk — it could be used to nudge behavior in real time. They started integrating with wearable devices and mobile apps, giving members personalized challenges and rewards for hitting step goals or getting their biometrics checked. And they used their claims data to identify gaps in care — like a diabetic who hasn't had an eye exam in eighteen months — and proactively reach out to them. Luna: So it's like a combination of big data and old-fashioned customer relationship management. But I bet there are privacy landmines everywhere. How do they square that with people being nervous about their health data being used for commercial purposes? Lucas: That's a real tension, and Aetna has had to be very careful. They use de-identified data for population-level analytics, and for individual outreach they always get opt-in consent. But the deeper issue is that the same data that can predict a heart attack can also be used to discriminate or deny coverage. So the trust question is existential for this pivot. Luna: And yet, if they get it right, the upside is enormous. Better health outcomes, lower costs, and a more loyal membership. It's a flywheel that could define the next generation of insurance. Lucas: It could. But it's not a done deal. Aetna's pivot is still a work in progress. They've made real strides, but they're also competing in a market where the traditional fee for service model is still dominant. And it's worth remembering that CVS Health acquired Aetna back in twenty eighteen, so this pivot now happens inside a company that also runs a massive pharmacy chain and a network of clinics. Luna: Oh right, that changes the calculus a little. CVS brings a lot of touchpoints — their stores, their pharmacists — that could be powerful for delivering preventive care. But it also complicates the story of a pure insurance pivot. Lucas: Exactly. It's not just an insurance company anymore; it's a health care delivery company that happens to have an insurance arm. And that integration is where a lot of the future potential lies — but also where a lot of execution risk sits. Luna: Before we go deeper into the CVS angle, I want to pause for a second. We're about to hit the halfway point of this episode, and I know our listeners have heard us mention before that this show is ad-free and supported by them. It feels like a good moment to remind people that the reason we can spend ten minutes on a nuanced topic like this is because of that support. Lucas: Yeah, that's a fair point. And it's not about big donations — it's the small monthly contributions that add up. A couple of dollars a month genuinely keeps the lights on. If you've gotten something useful out of the last one hundred fifty episodes, and this one in particular, maybe consider throwing something in the coffee can at buy me a coffee dot com slash fexingo. Luna: And it really does make a difference. We've been able to keep the show independent and dive into stories like this because of you. So thanks for that. Now, back to CVS — how much does the pharmacy side of the business change Aetna's original prevention strategy? Lucas: It supercharges it, potentially. Think about your local CVS pharmacy. Thousands of people walk through those doors every day, and the pharmacist is one of the most accessible health care professionals there is. Aetna's predictive data can tell you which of their members are overdue for a flu shot or a blood pressure check, and the CVS pharmacist can offer it right there on the spot. That's a level of convenience that a phone call or a mailed reminder can never match. Luna: And it also gives them an incredible distribution channel for the lifestyle programs — like the diabetes prevention program. Instead of sending people to a separate clinic, they can hold classes in the store's community room, or even embed a health coach right next to the pharmacy counter. Lucas: Exactly. And this is where the data science really shines. They can identify high-risk members who are already in the store for a prescription, and proactively offer them a consultation. The conversion rate on that kind of in-person intervention is going to be far higher than anything you can do through an app. Luna: But wait — there's a fine line between proactive and pushy. If I'm just trying to pick up my antibiotics, and the pharmacist tries to sign me up for a weight loss program, that could feel intrusive. Lucas: That's a real risk, and the privacy concerns we mentioned earlier become even more acute when you have a physical retail presence. It's one thing to get an email, another to have a pharmacist know your medical history. So Aetna and CVS have to be very deliberate about how they use that data and how they approach customers. They need to make it feel like a helpful suggestion, not a surveillance alert. Luna: So what does success look like? How do they measure whether this whole pivot is actually working, beyond just the stock price? Lucas: They look at health outcomes, not just claims costs. They track metrics like the number of members who get their recommended screenings, the rate of hospital readmissions, and yes, the overall cost curve for chronic conditions. And they've published some promising results — showing that their prevention programs reduced hospitalizations for high-risk members by double-digit percentages in some cohorts. But the ultimate test is whether they can sustain those improvements over many years and across a broad population. Luna: And that's where the long-term incentive problem comes back. Even with value-based contracts, the average member might still switch plans. So is there a way to make the benefits of prevention stick to the individual, not just the insurer? Lucas: That's the holy grail. One idea is portability — a health score or a set of health improvements that follow you from one insurer to the next, so your next plan can see that you've already gotten your blood pressure under control. That would change the competitive dynamics overnight, because insurers would compete on how good they are at improving people's health, not just how good they are at selecting healthy risks. Luna: That would be a massive shift. But it would require industry-wide cooperation and probably regulatory involvement. Do you see any signs of that happening? Lucas: A little. There are pilot programs and academic proposals around portable health records and even 'health passports.' And the federal government has been pushing for more interoperability of health data, which is a necessary foundation. But realistically, we're still a long way from full portability. In the meantime, Aetna is betting that keeping members engaged with their own health — through apps, wearables, and those in-store interactions — will create enough stickiness that people won't want to switch. That's their real retention play. Luna: So it's not just about cost savings; it's about building a relationship that transcends the annual enrollment period. That's a clever long-term strategy. Lucas: It's also a bet on the broader shift in health care toward value-based care. Aetna isn't the only one going this way, but they're one of the most aggressive. And because they have the CVS distribution network, they may actually have an edge over competitors who lack that physical presence. Luna: But let's play devil's advocate: could this entire approach backfire? What if the data models are wrong, or the interventions don't actually change behavior, and they just end up alienating customers and spending a fortune on programs that don't move the needle? Lucas: That's a real risk. The evidence for many wellness programs is mixed — a famous study at a large employer found that most such programs did not reduce costs or improve health outcomes significantly. The difference here is that Aetna is leveraging much richer clinical data and integrating with actual care delivery through CVS. But the history of health care is littered with well-intentioned interventions that failed to deliver. So the proof will be in the outcomes, which take years to measure. Luna: And in the meantime, they have to convince employers and members that this is worth the upfront investment. That's a tough sell when the payoff is far off and the costs are immediate. Lucas: It is. And that's why Aetna's pivot is so interesting — it's not just a product change, it's a fundamental bet on a different way of thinking about health insurance. If they succeed, they could redefine the industry. If they fail, they'll be a cautionary tale about the limits of data-driven health. Luna: So as we wrap up, what's the one takeaway you want listeners to have from this episode, other than the obvious 'prevention is better than cure'? Lucas: That the biggest obstacle to prevention isn't medical science — it's the business model. We know how to prevent most chronic diseases; we just haven't figured out how to pay for it in a way that any single company can profit from. Aetna's pivot is an attempt to solve that puzzle, and if they crack it, it could change health care for everyone. And that's a pretty fitting way to mark one hundred fifty episodes.